This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 May;204(5):e16-7; author reply e17.

doi: 10.1016/j.ajog.2010.12.001. Epub 2011 Jan 28.

17-hydroxyprogesterone caproate, progesterone, preterm birth prevention, and safety: who decides? Someone should

PMID: 21276949
DOI: 10.1016/j.ajog.2010.12.001

Comment

17-hydroxyprogesterone caproate, progesterone, preterm birth prevention, and safety: who decides? Someone should

John M O'Brien. Am J Obstet Gynecol. 2011 May.

. 2011 May;204(5):e16-7; author reply e17.

doi: 10.1016/j.ajog.2010.12.001. Epub 2011 Jan 28.

Author

PMID: 21276949
DOI: 10.1016/j.ajog.2010.12.001

Erratum in

Am J Obstet Gynecol. 2011 Nov;205(5):486

No abstract available

PubMed Disclaimer

Comment on

Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial.
Combs CA, Garite T, Maurel K, Das A, Porto M; Obstetrix Collaborative Research Network. Combs CA, et al. Am J Obstet Gynecol. 2010 Sep;203(3):248.e1-9. doi: 10.1016/j.ajog.2010.06.016. Am J Obstet Gynecol. 2010. PMID: 20816146 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources